Skip to main content
Top
Published in: Cancer Immunology, Immunotherapy 3/2004

01-03-2004 | Review

Exosome-based immunotherapy

Authors: Nathalie Chaput, Julien Taïeb, Noël E. C. Schartz, Fabrice André, Eric Angevin, Laurence Zitvogel

Published in: Cancer Immunology, Immunotherapy | Issue 3/2004

Login to get access

Abstract

Exosomes are small membrane vesicles originating from late endosomes and secreted by hematopoietic and epithelial cells in culture. Exosome proteic and lipid composition is unique and might shed some light into exosome biogenesis and function. Exosomes secreted from professional antigen-presenting cells (i.e., B lymphocytes and dendritic cells) are enriched in MHC class I and II complexes, costimulatory molecules, and hsp70–90 chaperones, and have therefore been more extensively studied for their immunomodulatory capacities in vitro and in vivo. This review will present the main biological features pertaining to tumor or DC-derived exosomes, will emphasize their immunostimulatory function, and will discuss their implementation in cancer immunotherapy.
Literature
1.
go back to reference Denzer K, Kleijmeer MJ, Heijnen HF, Stoorvogel W, Geuze HJ (2000) Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. J Cell Sci 113:3365–3374PubMed Denzer K, Kleijmeer MJ, Heijnen HF, Stoorvogel W, Geuze HJ (2000) Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. J Cell Sci 113:3365–3374PubMed
2.
go back to reference Denzer K, van Eijk M, Kleijmeer MJ, Jakobson E, de Groot C, Geuze HJ (2000) Follicular dendritic cells carry MHC class II-expressing microvesicles at their surface. J Immunol 165:1259–1265PubMed Denzer K, van Eijk M, Kleijmeer MJ, Jakobson E, de Groot C, Geuze HJ (2000) Follicular dendritic cells carry MHC class II-expressing microvesicles at their surface. J Immunol 165:1259–1265PubMed
3.
go back to reference Quah B, O’Neill HC (2000) The application of dendritic cell-derived exosomes in tumour immunotherpy. Cancer Biother Radiopharm 15:185–194PubMed Quah B, O’Neill HC (2000) The application of dendritic cell-derived exosomes in tumour immunotherpy. Cancer Biother Radiopharm 15:185–194PubMed
4.
go back to reference André F, Schartz NE, Movassagh M, Flament C, Pautier P, Morice P, Pomel C, Lhomme C, Escudier B, Le Chevalier T, Tursz T, Amigorena S, Raposo G, Angevin E, Zitvogel L (2002) Malignant effusions and immunogenic tumor derived-exosomes. Lancet 360:295–305CrossRefPubMed André F, Schartz NE, Movassagh M, Flament C, Pautier P, Morice P, Pomel C, Lhomme C, Escudier B, Le Chevalier T, Tursz T, Amigorena S, Raposo G, Angevin E, Zitvogel L (2002) Malignant effusions and immunogenic tumor derived-exosomes. Lancet 360:295–305CrossRefPubMed
5.
go back to reference Zitvogel L, Regnault A, Lozier A, Wolfers J, Flament C, Tenza D, Ricciardi-Castagnoli P, Raposo G, Amigorena S (1998) Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat Med 4:594–600PubMed Zitvogel L, Regnault A, Lozier A, Wolfers J, Flament C, Tenza D, Ricciardi-Castagnoli P, Raposo G, Amigorena S (1998) Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat Med 4:594–600PubMed
6.
go back to reference Wolfers J, Lozier A, Raposo G, Regnault A, Thery C, Masurier C, Flament C, Pouzieux S, Faure F, Tursz T, Angevin E, Amigorena S, Zitvogel L (2001) Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat Med 7:297–303PubMed Wolfers J, Lozier A, Raposo G, Regnault A, Thery C, Masurier C, Flament C, Pouzieux S, Faure F, Tursz T, Angevin E, Amigorena S, Zitvogel L (2001) Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat Med 7:297–303PubMed
7.
go back to reference Johnstone RM, Adam M, Hammond JR, Orr L, Turbide C (1987) Vesicle formation during reticulocyte maturation: association of plasma membrane activities with released vesicles (exosomes). J Biol Chem 262:9412–9420PubMed Johnstone RM, Adam M, Hammond JR, Orr L, Turbide C (1987) Vesicle formation during reticulocyte maturation: association of plasma membrane activities with released vesicles (exosomes). J Biol Chem 262:9412–9420PubMed
8.
go back to reference Raposo G, Tenza D, Mecheri S, Peronet R, Bonnerot C, Desaymard C (1997) Accumulation of major histocompatibility complex class II molecules in mast cell secretory granules and their release upon degranulation. Mol Biol Cell 8:2631–2645PubMed Raposo G, Tenza D, Mecheri S, Peronet R, Bonnerot C, Desaymard C (1997) Accumulation of major histocompatibility complex class II molecules in mast cell secretory granules and their release upon degranulation. Mol Biol Cell 8:2631–2645PubMed
9.
go back to reference Escola JM, Kleijmeer MJ, Stoorvogel W, Griffith JM, Yoshie O, Geuze HJ (1998) Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular endosomes and on exosomes secreted by human B-lymphocytes. J Biol Chem 273:20121–20127CrossRefPubMed Escola JM, Kleijmeer MJ, Stoorvogel W, Griffith JM, Yoshie O, Geuze HJ (1998) Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular endosomes and on exosomes secreted by human B-lymphocytes. J Biol Chem 273:20121–20127CrossRefPubMed
10.
go back to reference Arnold PY, Mannie MD (1999) Vesicles bearing MHC class II molecules mediate transfer of antigen-presenting cells to CD4+ cells. Eur J Immunol 29:1363–1373CrossRefPubMed Arnold PY, Mannie MD (1999) Vesicles bearing MHC class II molecules mediate transfer of antigen-presenting cells to CD4+ cells. Eur J Immunol 29:1363–1373CrossRefPubMed
11.
go back to reference Heijnen IA, van Vugt MJ, Fanger NA, Graziano RF, de Wit TP, Hofhuis FM, Guyre PM, Capel PJ, Verbeek JS, van de Winkel JG (1996) Antigen targeting to myeloid-specific human Fc gamma RI/CD64 triggers enhanced antibody responses in transgenic mice. J Clin Investig 97:331–338 Heijnen IA, van Vugt MJ, Fanger NA, Graziano RF, de Wit TP, Hofhuis FM, Guyre PM, Capel PJ, Verbeek JS, van de Winkel JG (1996) Antigen targeting to myeloid-specific human Fc gamma RI/CD64 triggers enhanced antibody responses in transgenic mice. J Clin Investig 97:331–338
12.
go back to reference Hess C, Sadallah S, Hefti A, Landmann R, Schifferli JA (1999) Ectosomes released by human neutrophils are specialized functional units. J Immunol 163:4564–4573PubMed Hess C, Sadallah S, Hefti A, Landmann R, Schifferli JA (1999) Ectosomes released by human neutrophils are specialized functional units. J Immunol 163:4564–4573PubMed
13.
go back to reference Patel DM, Arnold PY, White GA, Nardella JP, Mannie MD (1999) Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition. J Immunol 163:5201–5210PubMed Patel DM, Arnold PY, White GA, Nardella JP, Mannie MD (1999) Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition. J Immunol 163:5201–5210PubMed
14.
go back to reference Geminard C, Nault F, Johnstone RM, Vidal M (2001) Characteristics of the Interaction between Hsc70 and the transferrin receptor in exosomes released during reticulocyte maturation. J Biol Chem 276:9910–9916CrossRefPubMed Geminard C, Nault F, Johnstone RM, Vidal M (2001) Characteristics of the Interaction between Hsc70 and the transferrin receptor in exosomes released during reticulocyte maturation. J Biol Chem 276:9910–9916CrossRefPubMed
15.
go back to reference Skokos D, Le Panse S, Villa I, Rousselle JC, Peronet R, David B, Namane A, Mecheri S (2001) Mast cell-dependent B and T lymphocyte activation is mediated by the secretion of immunologically active exosomes. J Immunol 166:868–876PubMed Skokos D, Le Panse S, Villa I, Rousselle JC, Peronet R, David B, Namane A, Mecheri S (2001) Mast cell-dependent B and T lymphocyte activation is mediated by the secretion of immunologically active exosomes. J Immunol 166:868–876PubMed
16.
go back to reference Thery C, Zitvogel L, Amigorena S (2002) Exosomes: composition, biogenesis and function. Nat Rev Immunol 2:569–579PubMed Thery C, Zitvogel L, Amigorena S (2002) Exosomes: composition, biogenesis and function. Nat Rev Immunol 2:569–579PubMed
17.
go back to reference Yang S, Kittlesen D, Slingluff CL Jr, Vervaert CE, Seigler HF, Darrow TL (2000) Dendritic cells infected with a vaccinia vector carrying the human gp100 gene simultaneously present multiple specificities and elicit high-affinity T cells reactive to multiple epitopes and restricted by HLA-A2 and -A3. J Immunol 164(8):4204–4211PubMed Yang S, Kittlesen D, Slingluff CL Jr, Vervaert CE, Seigler HF, Darrow TL (2000) Dendritic cells infected with a vaccinia vector carrying the human gp100 gene simultaneously present multiple specificities and elicit high-affinity T cells reactive to multiple epitopes and restricted by HLA-A2 and -A3. J Immunol 164(8):4204–4211PubMed
18.
go back to reference Dhodapkar MV, Steinman RM, Krasovsky J, Munz C, Bhardwaj N (2001) Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J Exp Med 193:233–238PubMed Dhodapkar MV, Steinman RM, Krasovsky J, Munz C, Bhardwaj N (2001) Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J Exp Med 193:233–238PubMed
19.
go back to reference Chaput N, André F, Schartz NEC, Escudier B, Turz T, Angevin E, Zitvogel L (2003) Proc Am Assoc Cancer Res 44:A4746 Chaput N, André F, Schartz NEC, Escudier B, Turz T, Angevin E, Zitvogel L (2003) Proc Am Assoc Cancer Res 44:A4746
20.
go back to reference Théry C, Duban L, Segura E, Véron P, Lantz O, Amigorena S (2002) Exosomes activate naive CD4+ T cells by transfer of MHC/peptide complexes to dendritic cells. Nat Immunol 3:1156–1162CrossRefPubMed Théry C, Duban L, Segura E, Véron P, Lantz O, Amigorena S (2002) Exosomes activate naive CD4+ T cells by transfer of MHC/peptide complexes to dendritic cells. Nat Immunol 3:1156–1162CrossRefPubMed
21.
go back to reference Lamparski H, Metha-Damani A, Yao J, Patel S, Hsu D, Ruegg C, Le Pecq J (2002) Production and characterization of clinical grade exosomes derived from dendritic cells. J Immunol Meth 270(2):211 Lamparski H, Metha-Damani A, Yao J, Patel S, Hsu D, Ruegg C, Le Pecq J (2002) Production and characterization of clinical grade exosomes derived from dendritic cells. J Immunol Meth 270(2):211
22.
go back to reference H. Pêche (2001) Club Francophone Des Cellules Dendritiques, p 31 (Abstract C08) H. Pêche (2001) Club Francophone Des Cellules Dendritiques, p 31 (Abstract C08)
23.
go back to reference E. Angevin (2002) 7th International Symposium on Dendritic Cells, p 28 (Abstract 20) E. Angevin (2002) 7th International Symposium on Dendritic Cells, p 28 (Abstract 20)
Metadata
Title
Exosome-based immunotherapy
Authors
Nathalie Chaput
Julien Taïeb
Noël E. C. Schartz
Fabrice André
Eric Angevin
Laurence Zitvogel
Publication date
01-03-2004
Publisher
Springer-Verlag
Published in
Cancer Immunology, Immunotherapy / Issue 3/2004
Print ISSN: 0340-7004
Electronic ISSN: 1432-0851
DOI
https://doi.org/10.1007/s00262-003-0472-x

Other articles of this Issue 3/2004

Cancer Immunology, Immunotherapy 3/2004 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine